ONCOSEC MEDICAL INCORPORATED

NASDAQ

ONCS

When, I say that passion goes beyond the imagination, I am led back to this title, believe me, in many years of studies and research in the field of biotechnology, there have been many satisfactions compared to dispaires. Well if I told you that ONCS, in the second half of 2019 and in the first three months of 2020, will officially present TAVO to the world as a...

Simply testing.

*******POSSIBLE BREAKOUT IN BIO STOCK WITH NICE PRICE ACTION, INCREASED INTEREST AMONG TRADERS AS RUMORS AND SPECULATION FOLLOW THIS STOCK, KEEP ON WATCHLIST FOR A RAPID MOVE*************** AVERAGE ANALYSTS PRICE TARGET $9 AVERAGE ANALYSTS RECOMMENDATION BUY COMPANY PROFILE OncoSec Medical, Inc. is a biotechnology company, which engages in...

We got a double bottom here with an up gap in play. Waiting for volume to confirm. Purchasing at $.80 w/ a target of $1.20.

Spring play.

13 MARCH 2019 OncoSec to Present at the 31st Annual ROTH Conference ONCS ..pay attention here from 0.50 tp 1 1.4 $

ONCE LOOKING GOOD ON THE PULLBACK LIKE LONG ON STRENGTH

Oncosec Medical (ONCS) is a small biotech company focused on treating various cancers. The company is valued at less than $100M in market cap, which means investors aren’t giving much value to the long term potential of this speculative company. The company’s main platform is called Immunopulse. Immunopulse helps to deliver specific therapies into tumors. Using...

Look for reversal candles and increasing volume

ONCS has been range bound after finally finding a support after a nasty downtrend. Looking for an entry point with a stop at $1.30

Looks good for a u-shape breakout as indicators are pointing up. Nice rounded bottom looking to test the red line for resistance and possible selling point.

This is a very bulish chart something is going on with the big buys at the end of the day a lot of 13g's filed.

@jbzstocks

ONCS Long fuori da ledge

Looking to go long with Spark Theraputics (ONCE). It looks to be near support. I will use this as a long term buy and hold.

Usually clinical data isn't super positive on day 2 but these guys recently raised money, Point72 bought into the company. Almost no shares to short out there. Today I expect this to trade around 2.15 in decent size. Looking to buy on dips for instant profit and potentially hold some for a run up to $3

Expecting it to break upwards due to better formation and positive direction of MACD and positive squeeze/ momo w/ ~ 41% upside.

Just remember, $ONCE you're over the hill you begin to pick up speed